Chest pain and exacerbations of bronchiectasis

International Journal of General Medicine

Volumn 5, Issue , 2012, Pages 1019-1024

  King, Paul T ^a,b   Holdsworth, Stephen R ^b   Farmer, Michael ^a   Freezer, Nicholas J ^a   Holmes, Peter W ^a  

^a MONASH MEDICAL CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Airway obstruction; Bronchitis; Collapse; Sputum

Indexed keywords

ADULT; ARTICLE; BRONCHIECTASIS; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PROSPECTIVE STUDY; SEX DIFFERENCE; SYNDROME DELINEATION; THORAX PAIN; THORAX RADIOGRAPHY;

EID: 84877121976     PISSN: None     EISSN: 11787074     Source Type: Journal    
DOI: 10.2147/IJGM.S39280     Document Type: Article

References (32)

1. Fillenz M, Widdicombe JG. Receptors of the lungs and airways. In: Neil E, editor. Handbook of Sensory Physiology: Enteroceptors. Berlin: Springer-Verlag; 1971:81-112.
2. Paintal AS. The visceral sensations, some basic mechanisms. In: Cervero F, Morrison J, editors. Progress in Brain Research. Visceral Sensation. Amsterdam: Elsevier; 1986;67:3-19.
3. Widdicombe JG. Sensory innervation of the lungs and airways. Prog Brain Res. 1986;67:49-64.
4. King PT, Holdsworth SR, Freezer NJ, Holmes PW. Bronchiectasis. Intern Med J. 2006;36(11):729-737.
5. Patel IS, Vlahos I, Wilkinson TM, et al. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170(4):400-407.
6. Barker AF. Bronchiectasis. N Engl J Med. 2002;346(18):1383-1393.
7. McGuinness G, Naidich DP. CT of airways disease and bronchiectasis. Radiol Clin North Am. 2002;40(1):1-19.
8. King PT, Holdsworth SR, Freezer NJ, Villanueva E, Gallagher M, Holmes PW. Outcome in adult bronchiectasis. COPD. 2005;2(1):27-34.
9. Lynch ME, Clark AJ, Sawynok J, Sullivan MJ. Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial. Anesthesiology. 2005;103(1):140-146.
10. Maier C, Hildebrandt J, Klinger R, Henrich-Eberl C, Lindena G; MONTAS Study Group. Morphine responsiveness, efficacy and tolerability in patients with chronic non-tumor associated pain-results of a double-blind placebo-controlled trial (MONTAS). Pain. 2002;97(3): 223-233.
11. Hollen PJ, Gralla RJ, Kris MG, McCoy S, Donaldson GW, Moinpour CM. A comparison of visual analogue and numerical rating scale formats for the Lung Cancer Symptom Scale (LCSS): does format affect patient ratings of symptoms and quality of life? Qual Life Res. 2005;14(3): 837-847.
12. Cervero F. Sensory innervation of the viscera: peripheral basis of visceral pain. Physiol Rev. 1994;74(1):95-138.
13. Lewis T. Pain. New York, NY: MacMillan; 1942.
14. Bonica JJ. The Management of Pain, 2nd ed. Philadelphia, PA: Lea and Febiger; 1990.
15. King PT. Painful disorders of the respiratory system. In: Waldman SD, editor. Pain Management, 2nd ed. Philadelphia, PA: Elsevier; 2011:1763-1771.
16. Paintal AS. Thoracic receptors connected with sensation. Br Med Bull. 1977;33(2):169-174.
17. Coleridge JC, Coleridge HM. Functional role of pulmonary rapidly adapting receptors and lung C fibers. In: Lahiri S, Forster RE, Davies RO, Pack A, editors. Chemoreceptors and Reflexes in Breathing. New York, NY: Oxford University Press; 1989:287-292.
18. Paintal AS. Vagal sensory receptors and their reflex effects. Physiol Rev. 1973;53(1):159-227.
19. Murray JF, Gebhart G. Chest pain. In: Murray JF, Nadal JA, editors. Textbook of Respiratory Medicine, 3rd ed. Philadelphia, PA: WB Saunders; 2000:567-571.
20. Coleridge JC, Coleridge HM. Afferent vagal C fibre innervation of the lungs and airways and its functional significance. Rev Physiol Biochem Pharmacol. 1984;99:1-110.
21. King PT, Holdsworth SR, Freezer NJ, Villanueva E, Holmes PW. Characterisation of the onset and presenting clinical features of adult bronchiectasis. Respir Med. 2006;100(12):2183-2189.
22. Chang AB, Bilton D. Exacerbations in cystic fibrosis: 4-Non-cystic fibrosis bronchiectasis. Thorax. 2008;63(3):269-276.
23. O'Donnell AE, Barker AF, Ilowite JS, Fick RB. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group. Chest. 1998;113(5):1329-1334.
24. Cymbala AA, Edmonds LC, Bauer MA, et al. The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis. Treat Respir Med. 2005;4(2):117-122.
25. Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest. 2000;117(5 Suppl 2):398S-401S.
26. Martínez-García MA, Soler-Cataluña JJ, Perpiñá-Tordera M, Román-Sánchez P, Soriano J. Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest. 2007;132(5):1565-1572.
27. Levene DL. Pain arising from intrathoracic structures. Chest Pain: An Integrated Diagnostic Approach. Philadelphia, PA: Lea and Febiger; 1977:71-75.
28. Nicotra MB, Rivera M, Dale AM, Shepherd R, Carter R. Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort. Chest. 1995;108(4):955-961.
29. Fuschillo S, De Felice A, Balzano G. Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms. Eur Respir J. 2008;31(2):396-406.
30. Zakrzewski JT, Barnes NC, Costello JF, Piper PJ. Lipid mediators in cystic fibrosis and chronic obstructive pulmonary disease. Am Rev Respir Dis. 1987;136(3):779-782.
31. King PT. Non-pleuritic chest pain and recurrent lobar collapse. Respir Med CME. 2009;2(3):125-127.
32. Flasar MH, Goldberg E. Acute abdominal pain. Med Clin North Am. 2006;90(3):481-503.